August 2013 FDA Recall Extended Phenytoin Sodium by Amneal Pharmaceuticals Of New York, Llc.
D-66014-001 - Failed dissolution specifications; 18 month CRT

This Class II drug recall was voluntarily initiated by Amneal Pharmaceuticals Of New York, Llc. on August 17, 2013 for the product Extended Phenytoin Sodium. The FDA reported the reason for recall as failed dissolution specifications; 18 month crt. The product was distributed in IL, NH, NJ, NY, OH, RI, TN and the recall is currently terminated.

Recall Number: D-66014-001

Reason for Recall
Failed dissolution specifications; 18 month CRT
Initiated
08-17-2013
Reported
11-13-2013
Quantity
895 - 1000 count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Amneal Pharmaceuticals of New York, LLC.
IL, NH, NJ, NY, OH, RI, TN
Extended Phenytoin Sodium Capsules, USP, 100 mg, 1000 CAPSULES, Rx only, amneal PHARMACEUTICALS label, NDC 65162-212-11 --- Manufactured by: Amneal Pharmaceuticals of NY Hauppauge, NY 11788 Distributed by: Amneal Pharmaceuticals Glasgow, KY 42141

Batch or Lot Expiration Information

Lot# Batch/Lot HL50611, exp. 1/2014